BioTech
Drug makers already bet big on mRNA for cancer. Why is Biden going in, too?
WASHINGTON — President Biden’s fledgling health agency, designed to accelerate under-funded research, just set its sights on one of the hottest areas of medicine —
Damian Garde and Sarah Owermohle
August 24, 2023